Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
13
Participants
Timeline
Start Date
October 1, 2014
Primary Completion Date
April 2, 2019
Study Completion Date
April 2, 2019
Conditions
Thyroid Cancer
Interventions
RADIATION
Radium 223
Trial Locations (1)
94805
Gustave Roussy, Villejuif
All Listed Sponsors
lead
Gustave Roussy, Cancer Campus, Grand Paris
OTHER
NCT02390934 - Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer | Biotech Hunter | Biotech Hunter